# End-of-Life Care: Stakeholders

## Who Is Affected

### Primary Stakeholders

| Group | Impact | Size |
|-------|--------|------|
| **Dying patients** | Quality of death, symptom control, location | 3.4 million annually |
| **Family caregivers** | Care burden, bereavement, financial impact | 10+ million annually |
| **People with serious illness** | Quality of life, treatment decisions | 15+ million |
| **Hospice patients** | Access, timing, quality of care | 1.7 million |
| **Nursing home residents** | End-of-life care quality | 1.3 million at any time |

### Patients Facing End of Life

| Condition | Annual Deaths | Hospice Eligible |
|-----------|--------------|------------------|
| Cancer | 600,000 | Most |
| Heart disease | 700,000 | Many, but harder to predict |
| Dementia | 120,000+ | Many, but often late referral |
| Lung disease | 150,000 | Many |
| Stroke | 160,000 | Variable |
| Kidney disease | 55,000 | Many |

### Family Caregivers

| Characteristic | Data |
|----------------|------|
| Annual unpaid care | $500+ billion value |
| Hours per week | 20+ hours average |
| Employment impact | 60% work while caregiving |
| Health impact | Higher mortality, depression |
| Post-death impact | 20% develop complicated grief |

### Secondary Stakeholders

| Group | Connection to EOL Care |
|-------|----------------------|
| **Children of dying** | Decision-making, bereavement |
| **Spouses** | Primary caregivers, surrogates |
| **Healthcare workers** | Moral distress, burnout |
| **Employers** | Caregiver absence, productivity |
| **Communities** | Support systems, death rituals |
| **Faith communities** | Spiritual support, counseling |

## Who Has Power

### Government Decision Makers

| Actor | Authority | EOL Impact |
|-------|-----------|------------|
| **Congress** | Medicare benefit design | Hospice structure, ACP payment |
| **CMS** | Medicare/Medicaid rules | Payment rates, quality measures |
| **HHS** | Health policy coordination | Research, guidance |
| **State legislatures** | Medical aid in dying, health law | Varies by state |
| **State health departments** | Licensing, oversight | Hospice regulation |

### Regulatory Bodies

| Body | Role |
|------|------|
| **CMS** | Hospice conditions of participation |
| **Joint Commission** | Hospital/hospice accreditation |
| **State health departments** | Facility licensing |
| **Medical boards** | Physician practice standards |
| **CHAP/ACHC** | Hospice accreditation |

### Healthcare System Actors

| Actor | Power | Interest |
|-------|-------|----------|
| **Hospital systems** | Control care delivery | Revenue, reputation |
| **Hospice organizations** | Direct care provision | Market share, sustainability |
| **Health insurers** | Coverage decisions | Cost management |
| **Physicians** | Clinical decisions, referrals | Income, professional identity |
| **Nursing homes** | Care setting for many deaths | Occupancy, regulation |

## Key Organizations

### Professional Associations

| Organization | Focus | Influence |
|--------------|-------|-----------|
| **AAHPM** | Palliative medicine | Practice standards, education |
| **HPNA** | Hospice/palliative nursing | Nursing standards |
| **NHPCO** | Hospice providers | Industry advocacy |
| **CAPC** | Palliative care quality | Hospital program support |
| **AMA** | Physician advocacy | EOL policy positions |
| **AHA** | Hospital systems | Policy influence |

### Advocacy Organizations

| Organization | Mission | Approach |
|--------------|---------|----------|
| **Compassion & Choices** | End-of-life options | Medical aid in dying advocacy |
| **Coalition for Compassionate Care** | ACP, palliative care | State-level advocacy |
| **National Hospice Foundation** | Hospice access | Education, awareness |
| **Death with Dignity** | Assisted dying laws | State campaigns |
| **Five Wishes** | Advance planning | Document distribution |
| **The Conversation Project** | ACP conversations | Public engagement |

### Research and Education

| Organization | Role |
|--------------|------|
| **Palliative Care Research Cooperative** | Research network |
| **AHRQ** | Healthcare quality research |
| **NIA** | Aging research including EOL |
| **Hastings Center** | Bioethics |
| **CAPC** | Education, hospital programs |

## Stakeholder Interests Matrix

| Stakeholder | Primary Interest | EOL Position |
|-------------|------------------|--------------|
| Dying patients | Comfort, dignity, choice | Want quality over quantity |
| Family caregivers | Support, guidance, peace | Want help and closure |
| Hospice providers | Sustainability, quality | Earlier referrals, payment stability |
| Hospitals | Revenue, reputation | Ambivalent; EOL costs and ethics |
| Physicians | Professional satisfaction | Often conflict between training and preferences |
| Insurers | Cost management | Support hospice/palliative (saves money) |
| Religious groups | Moral/spiritual concerns | Varies widely by tradition |
| Nursing homes | Regulatory compliance | Managing death as part of care |

## Power Analysis

### High Power, High Interest

| Actor | Power Source | Priority |
|-------|--------------|----------|
| **CMS** | Payment authority | Payment reform, quality |
| **Congress** | Appropriations, legislation | Benefit design |
| **Hospital systems** | Care delivery control | Revenue protection |
| **Hospice industry** | Service provision | Business sustainability |

### High Power, Lower Interest

| Actor | Power Source | Current Engagement |
|-------|--------------|-------------------|
| **Private insurers** | Coverage decisions | Follow Medicare; cost savings interest |
| **Large physician groups** | Political influence | Peripheral to main concerns |
| **Pharmaceutical companies** | Lobbying power | Limited EOL drug market |

### High Interest, Lower Power

| Actor | Interest | Constraint |
|-------|----------|------------|
| **Patients and families** | Direct impact | Fragmented, crisis-focused |
| **Palliative care advocates** | Field development | Limited resources |
| **Death with dignity movement** | Legal change | State-by-state battles |
| **Researchers** | Evidence generation | Funding limitations |

### Low Power, Lower Interest

| Actor | Relationship | Potential |
|-------|--------------|-----------|
| **General public** | Future patients | Mobilizable with messaging |
| **Employers** | Caregiver productivity | Could be engaged |
| **Faith communities** | Spiritual support | Variable engagement |

## Coalition Dynamics

### Reform Coalition

| Member | Contribution | Motivation |
|--------|--------------|------------|
| Palliative care professionals | Expertise, clinical leadership | Field growth |
| Hospice providers | Service delivery | Enrollment, payment |
| Patient advocates | Moral authority | Patient welfare |
| Some insurers | Cost data | Savings from hospice/palliative |
| Researchers | Evidence | Science advancement |

**Coalition strengths**: Expertise, patient stories, cost arguments
**Coalition weaknesses**: Limited political clout, fragmented voice

### Status Quo Coalition

| Member | Interest | Concern |
|--------|----------|---------|
| Hospital lobby | Revenue | Payment shifts away from hospitals |
| Some religious groups | Sanctity of life | Slippery slope fears |
| Some specialty physicians | Income | Procedure reduction |
| Anti-euthanasia activists | Moral objection | Aid in dying expansion |

### Swing Stakeholders

| Actor | Could Support If... |
|-------|-------------------|
| Hospital systems | Payment neutral, quality focus |
| Primary care physicians | Time compensated, training provided |
| Religious moderates | Patient choice emphasized, not euthanasia |
| Conservative politicians | Cost savings, family values framing |

## Stakeholder Engagement Strategies

### For Patients and Families

| Strategy | Approach |
|----------|----------|
| Storytelling | Personal narratives of good and bad deaths |
| Education | Help people understand options |
| Activation | Support for advocacy involvement |
| Support services | Caregiver assistance during and after |

### For Healthcare Providers

| Strategy | Approach |
|----------|----------|
| Training | Communication skills, palliative expertise |
| Systems support | Time for conversations, EHR tools |
| Quality feedback | Data on their patients' outcomes |
| Professional identity | Reframe comfort care as success |

### For Policymakers

| Strategy | Approach |
|----------|----------|
| Cost evidence | Document savings from better EOL care |
| Quality data | Show patient preference alignment |
| Bipartisan framing | Avoid culture war triggers |
| Constituent stories | Personal impact narratives |

---

## Document Navigation

- Previous: [Root Causes](04-root-causes.md)
- Next: [Opposition](06-opposition.md)
